$4.93
-0.31-5.92%
Dern. MÀJ: Nov 17, 1:15 PM

The average analyst price target for aTyr Pharma is $46, 833.1% above the current price. Of 8 analysts, 2 rate it Buy and 6 Hold. Targets range from $4 to $140. The latest change came on Nov 6, 2026, when RBC Capital lowered its price target on aTyr Pharma from $40 to $6 and kept a Sector Perform rating.
Price Target Range — 10 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months